Source link : https://www.newshealth.biz/health-news/hydroxyurea-shows-some-benefits-in-milder-sickle-cell-disease/
SAN DIEGO — Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a Ghanaian randomized phase II trial showed. Hematologic DLTs — mostly mild and transient — occurred in 33% of patients taking hydroxyurea compared with 11% of […]
Author : News Health
Publish date : 2024-12-09 20:26:29
Copyright for syndicated content belongs to the linked Source.